Showing 1331-1340 of 5016 results for "".
Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-35/23723/Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-3/23049/The Role of Inflammation in Acne Vulgaris
https://practicaldermatology.com/topics/general-topics/the-role-of-inflammation-in-acne-vulgaris/21512/Multiple lines of evidence support a pivotal role for inflammation in the pathogenesis of acne vulgaris.Treatment Guidelines for the PicoWay® Laser System in Skin of Color
https://practicaldermatology.com/topics/general-topics/treatment-guidelines-for-the-picoway-laser-system-in-skin-of-color/22087/Picosecond laser therapy for benign pigmented lesionsHome-Use Laser and Light Devices: Just What the Doctor Ordered
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/home-use-laser-and-light-devices-just-what-the-doctor-ordered/23335/Laser and light-based devices are more at home than ever as lightweight LEDs, wearable technology, and “smart” apps support adherence and enhance efficacy.Dealing with the Crazy Cost Curve in Dermatologic Drugs
https://practicaldermatology.com/topics/practice-management/dealing-with-the-crazy-cost-curve-in-dermatologic-drugs/20376/Dermatologists, desperate for relief from the forces that have sent prices skyrocketing, are pushing for reform or exploring other options.Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/20477/The HRQoL Impact of Psoriasis: Perspectives for Value-Based Reimbursement
https://practicaldermatology.com/topics/psoriasis/the-hrqol-impact-of-psoriasis-perspectives-for-value-based-reimbursement/20932/Understanding the psychological/social burden of psoriasis on patients is critical as new therapeutics position themselves for reimbursement in a crowded and increasingly undifferentiated field.Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-1/22980/Biologics for Psoriasis: A Status Update
https://practicaldermatology.com/topics/psoriasis/biologics-for-psoriasis-a-status-update/23006/The field has grown substantially from the early 2000s to include now a dozen innovator systemic agents, a host of biosimilars, and soon JAK Inhibitors.